ÂÜÀòÂÒÂ×

Guy Yeoman has extensive experience in the pharmaceutical and medical affairs sectors, currently serving as Vice President and Global Head of Clinical Development and Medical Affairs at Mallinckrodt Pharmaceuticals since November 2020, where also holds the role of Head of International Medical. Previously, Guy Yeoman was involved with MediPaCe from February 2018 to May 2023 as a Non-Executive Director and Strategic Lead (Founder). Prior to that, significant contributions were made at AstraZeneca from May 2012 to December 2017 as Vice President of Patient Centricity and Vice President of Medical Evidence within Global Medical Affairs, having earlier roles from 2008 to 2012 that included Regional Medical Director for Asia Pacific. Guy Yeoman started their professional career at Servier Laboratories as Director of Medical and Corporate Affairs in the UK from 2005 to 2008. Educational credentials include a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree obtained at the Royal London Hospital from 1985 to 1990, complemented by foundational education at Sedbergh from 1979 to 1984.